CULT Food Science, an alt-protein investment platform, announces its portfolio company CELL AG TECH is collaborating with the Centre for Commercialization of Regenerative Medicine (CCRM) to efficiently scale CELL AG’s cultured seafood manufacturing. CELL AG has also been named a winner in Canada’s AcCELLerate-ON competition for its work on scaling fish muscle stem cells in 2D and 3D.
“Organizations that excel in complementary fields”
As part of the signed agreement, CELL AG and CCRM’s scientists will work on developing a cost-effective and efficient process for growing fish cells in bioreactors. A leader in regenerative medicine-based technologies, CCRM’s cell manufacturing knowledge and ability to apply regenerative medicine principles to cell culturing will accelerate CELL AG’s development processes and improve product quality, the startup says.
Though the scaling of cell-based fish and seafood is largely still in its early stages, CELL AG is working diligently to bring healthy, environmentally-friendly and cruelty-free cultured seafood to the consumer market, beginning with lean white fish.
A winning pitch
CELL AG was also named a winner in AcCELLerate-ON, Canada’s first regional cellular agriculture competition. The startup’s successful pitch showed how it plans to use proteomics to optimize the growth of snapper cells in 2D and 3D culturing systems, which will prepare the product for commercialization.
“A collaboration with CCRM aligns well with our development strategy where we focus on our core expertise while benefiting from and leveraging the experience, capabilities and infrastructure of organizations that excel in complementary fields important to cellular agriculture. Working with the best organizations in their respective fields and being recognized nationally for our continued development as a company will allow us to efficiently accomplish our goals,” said Josh Pollack, Co-Founder of CELL AG.